Trubion Pharma (TRBN) Posts Q3 Loss of 33c, Beats Street by 10c; Cuts Burn Rate
Trubion Pharmaceuticals, Inc (NASDAQ: TRBN) reports Q3 adjusted loss of $0.33, 10 cents better than the analyst estimate of ($0.43). Revenue for the quarter was $4.5 million, which compares to the estimate of $4.98 million.
Cuts forecast for year burn rate from $30 - $35 million, to $0 - $5 million, reaffirms FY09 outlook for sales.
Cuts forecast for year burn rate from $30 - $35 million, to $0 - $5 million, reaffirms FY09 outlook for sales.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
